Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trial.
Saved in:
| Title: | Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trial. |
|---|---|
| Authors: | Hall N; Public Health Center, CH Quimper, Quimper, France., Allavena C; Department of Infectious Diseases, CHU Nantes, INSERM UIC 1413, CHU Nantes, Hôtel-Dieu University Hospital, 1 Place Alexis-Ricordeau, 44000, Nantes, France., Katlama C; Department of Infectious Diseases, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France., Jobert A; Sponsor Department, CHU Nantes, Nantes, France., Molina JM; Department of Infectious Diseases, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université de Paris Diderot, Sorbonne Paris Cité, INSERM UMR 941, Paris, France., Cua E; Department of Infectious Diseases, Hôpital de l'Archet, Centre Hospitalier de Nice, Nice, France., Bani-Sadr F; Department of Internal Medicine, Infectious Diseases, and Clinical Immunology, Reims Teaching Hospitals, University of Reims, Reims, France., Hocqueloux L; Department of Infectious Diseases, CHR d'Orléans, Orléans, France., Duvivier C; AP-HP-Necker Hospital, Infectious Diseases Department, Necker-Pasteur Infectiology Centre, Paris, France., Merrien D; Department of Infectious Diseases, CHD Vendee, La Roche sur yon, France., Hikombo H; Infectious and Tropical Diseases Department, Le Mans General Hospital, Le Mans, France., André-Garnier E; Virology Laboratory CHU Hôtel Dieu and INSERM CIC 1413 Nantes University, Nantes, France., Gaultier A; Department of Biostatistics, CHU de Nantes, Direction de la recherche, Nantes, France., Raffi F; Department of Infectious Diseases, CHU Nantes, INSERM UIC 1413, CHU Nantes, Hôtel-Dieu University Hospital, 1 Place Alexis-Ricordeau, 44000, Nantes, France. francois.raffi@wanadoo.fr. |
| Corporate Authors: | QDISS Study Group |
| Source: | AIDS research and therapy [AIDS Res Ther] 2022 Jan 15; Vol. 19 (1), pp. 4. Date of Electronic Publication: 2022 Jan 15. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101237921 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-6405 (Electronic) Linking ISSN: 17426405 NLM ISO Abbreviation: AIDS Res Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35033092 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hall+N%22">Hall N</searchLink>; Public Health Center, CH Quimper, Quimper, France.<br /><searchLink fieldCode="AU" term="%22Allavena+C%22">Allavena C</searchLink>; Department of Infectious Diseases, CHU Nantes, INSERM UIC 1413, CHU Nantes, Hôtel-Dieu University Hospital, 1 Place Alexis-Ricordeau, 44000, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Katlama+C%22">Katlama C</searchLink>; Department of Infectious Diseases, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Jobert+A%22">Jobert A</searchLink>; Sponsor Department, CHU Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Molina+JM%22">Molina JM</searchLink>; Department of Infectious Diseases, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université de Paris Diderot, Sorbonne Paris Cité, INSERM UMR 941, Paris, France.<br /><searchLink fieldCode="AU" term="%22Cua+E%22">Cua E</searchLink>; Department of Infectious Diseases, Hôpital de l'Archet, Centre Hospitalier de Nice, Nice, France.<br /><searchLink fieldCode="AU" term="%22Bani-Sadr+F%22">Bani-Sadr F</searchLink>; Department of Internal Medicine, Infectious Diseases, and Clinical Immunology, Reims Teaching Hospitals, University of Reims, Reims, France.<br /><searchLink fieldCode="AU" term="%22Hocqueloux+L%22">Hocqueloux L</searchLink>; Department of Infectious Diseases, CHR d'Orléans, Orléans, France.<br /><searchLink fieldCode="AU" term="%22Duvivier+C%22">Duvivier C</searchLink>; AP-HP-Necker Hospital, Infectious Diseases Department, Necker-Pasteur Infectiology Centre, Paris, France.<br /><searchLink fieldCode="AU" term="%22Merrien+D%22">Merrien D</searchLink>; Department of Infectious Diseases, CHD Vendee, La Roche sur yon, France.<br /><searchLink fieldCode="AU" term="%22Hikombo+H%22">Hikombo H</searchLink>; Infectious and Tropical Diseases Department, Le Mans General Hospital, Le Mans, France.<br /><searchLink fieldCode="AU" term="%22André-Garnier+E%22">André-Garnier E</searchLink>; Virology Laboratory CHU Hôtel Dieu and INSERM CIC 1413 Nantes University, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Gaultier+A%22">Gaultier A</searchLink>; Department of Biostatistics, CHU de Nantes, Direction de la recherche, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Raffi+F%22">Raffi F</searchLink>; Department of Infectious Diseases, CHU Nantes, INSERM UIC 1413, CHU Nantes, Hôtel-Dieu University Hospital, 1 Place Alexis-Ricordeau, 44000, Nantes, France. francois.raffi@wanadoo.fr. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22QDISS+Study+Group%22">QDISS Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101237921%22">AIDS research and therapy</searchLink> [AIDS Res Ther] 2022 Jan 15; Vol. 19 (1), pp. 4. <i>Date of Electronic Publication: </i>2022 Jan 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101237921 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1742-6405 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217426405%22">17426405 </searchLink><i>NLM ISO Abbreviation: </i>AIDS Res Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35033092 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12981-022-00428-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4 Titles: – TitleFull: Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hall N – PersonEntity: Name: NameFull: Allavena C – PersonEntity: Name: NameFull: Katlama C – PersonEntity: Name: NameFull: Jobert A – PersonEntity: Name: NameFull: Molina JM – PersonEntity: Name: NameFull: Cua E – PersonEntity: Name: NameFull: Bani-Sadr F – PersonEntity: Name: NameFull: Hocqueloux L – PersonEntity: Name: NameFull: Duvivier C – PersonEntity: Name: NameFull: Merrien D – PersonEntity: Name: NameFull: Hikombo H – PersonEntity: Name: NameFull: André-Garnier E – PersonEntity: Name: NameFull: Gaultier A – PersonEntity: Name: NameFull: Raffi F IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 01 Text: 2022 Jan 15 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1742-6405 Numbering: – Type: volume Value: 19 – Type: issue Value: 1 Titles: – TitleFull: AIDS research and therapy Type: main |
| ResultId | 1 |